Neal Castagnoli - Concepedia

Author

Neal Castagnoli

Also Known As

N Castagnoli, N. CASTAGNOLI, N. Castagnoli, Neal CASTAGNOLI Jr., Neal Castagnoli, Neal Castagnoli Jr, Neal Castagnoli Jr., Neal Castagnoli,, Neal Jr. Castagnoli

Publications

Citations

H-Index

Concepts

All Affiliations

Virginia Tech AstraZeneca (Sweden)Massachusetts General Hospital

About

Neal Castagnoli is an author at Virginia Tech specializing in pharmacology, biochemistry, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	11	11	292
2	Medicine	10	10	850
3	Engineering	3	3	48
4	Arts	1	1	36
5	Public Health	1	1	36

Neal Castagnoli

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer, PubMed Common ConsumptionNeurotransmitterPharmacotherapySocial SciencesMolecular Pharmacology	2001	509
A convenient synthesis of quinones from hydroquinone dimethyl ethers. Oxidative demethylation with ceric ammonium nitrate Peyton Jacob, Patrick S. Callery, Alexander T. Shulgin, The Journal of Organic Chemistry Derivative (Chemistry)Hydroquinone Dimethyl EthersPharmacologyAltmetric Attention ScoreOrganic Chemistry	1976	284
8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism Jiang‐Fan Chen, Salome Steyn, Roland G. W. Staal, Journal of Biological Chemistry	2002	116
Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues Deidré van den Berg, Kevin Robert Zoellner, Modupe O. Ogunrombi, Bioorganic & Medicinal Chemistry Medicinal ChemistryMonoamine Oxidase BPharmacological StudyBiochemistryMedicine	2007	73
Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco Kay Castagnoli, Stefanus J. Steyn, Jacobus P. Petzer, Chemical Research in Toxicology NeuropeptidesBiochemistryMedicineNicotineCompound Isolated	2001	58
Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine] Zhiyang Zhao, Neal Castagnoli, George A. Ricaurte, Chemical Research in Toxicology	1992	55
Cotinine N-oxide, a new metabolite of nicotine Ermias Dagne, Neal Castagnoli Journal of Medicinal Chemistry Molecular PharmacologyCotinine N-oxideTherapeutic Drug MonitoringMedicineNicotine	1972	51
<i>tert</i>-Butoxyl as a Model for Radicals in Biological Systems: Caveat Emptor James M. Tanko, Robert Friedline, N. Kamrudin Suleman, Journal of the American Chemical Society Redox SignalingMolecular SciencesChemical AnalysisBiochemistryMedicine	2001	41
Synthesis, Structural Reassignment, and Biological Activity of Type B MAO Inhibitors Based on the 5<i>H</i>-Indeno[1,2-<i>c</i>]pyridazin-5-one Core Raphaël Frédérick, Willy Dumont, Frédéric Ooms, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryEnzyme Inhibitor PropertiesOrganic ChemistryChemistry	2006	38
Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+ Toshihiro Shinka, Patricia Caldera-Munoz, Hideo Yoshizumi, Chemical Research in Toxicology	1988	37

Page 1